Research Impact

h-index

N/A

Research impact score

Publications

0

Total publications

Trial Results

0

Published trial results

Citations

0

Total citations

Drug Portfolio

Analytics

Trial Phases

Phase 21

Trial Status

Terminated1

Role Distribution

Principal Investigator1
PI Rate100%

Activity Timeline

Clinical Trials (1)

NCT03439085Phase 2Terminated
DNA Plasmid-encoding Interleukin-12/HPV DNA Plasmids Therapeutic Vaccine INO-3112 and Durvalumab in Treating Patients With Recurrent or Metastatic Human Papillomavirus Associated Cancers
Human Papillomavirus-16 PositiveHuman Papillomavirus-18 PositiveMetastatic Malignant Neoplasm+18 more
PrincipalinvestigatorStart date: 2018-11-14

Research Network

Collaboration Network

1 collaborators·0 connections
Network Legend
KOL
Current Investigator
CO
High-influence Collaborator
CO
Collaborator
Click: view details
Double-click: go to profile
Drag: move node

Similar Key Opinion Leaders

Discover other key opinion leaders with similar research profiles, therapeutic areas, and collaboration networks.

10 similar investigators found

Lilie L Lin

M.D. Anderson Cancer Center

Related
5 trials

Shared therapeutic areas:

Recurrent Cervical CarcinomaRecurrent Vaginal CarcinomaStage IV Cervical Cancer AJCC v8+9 more

Worked with same sponsors:

M.D. Anderson Cancer CenterNational Cancer Institute (NCI)
Similarity Score17%

Roy Strowd, MD

Wake Forest University Health Sciences

Related
7 trials

Shared therapeutic areas:

Recurrent Cervical CarcinomaRecurrent Vulvar CarcinomaStage IV Cervical Cancer AJCC v8+5 more

Worked with same sponsors:

National Cancer Institute (NCI)
Similarity Score11%

Laleh Melstrom

City of Hope Medical Center

Related
2 trials

Shared therapeutic areas:

Stage IV Cervical Cancer AJCC v8Stage IVA Cervical Cancer AJCC v8Stage IVB Cervical Cancer AJCC v8

Worked with same sponsors:

National Cancer Institute (NCI)
Similarity Score4%

Sarina A Piha-Paul

M.D. Anderson Cancer Center

Related
4 trials

Shared therapeutic areas:

Metastatic Malignant NeoplasmRecurrent Malignant NeoplasmRefractory Malignant Neoplasm

Worked with same sponsors:

M.D. Anderson Cancer CenterNational Cancer Institute (NCI)
Similarity Score4%

Allison M Quick, MD

Ohio State University Comprehensive Cancer Center

Related
2 trials

Shared therapeutic areas:

Stage IVA Cervical Cancer AJCC v8Stage IVA Vaginal Cancer AJCC v8Stage IVA Vulvar Cancer AJCC v8
Similarity Score4%

Sriram Yennu

M.D. Anderson Cancer Center

Related
12 trials

Shared therapeutic areas:

Metastatic Malignant NeoplasmRecurrent Malignant NeoplasmRefractory Malignant Neoplasm

Worked with same sponsors:

M.D. Anderson Cancer CenterNational Cancer Institute (NCI)
Similarity Score4%

Sarina Piha-Paul, MD

M.D. Anderson Cancer Center

Related
5 trials

Shared therapeutic areas:

Metastatic Malignant NeoplasmRecurrent Malignant NeoplasmRefractory Malignant Neoplasm

Worked with same sponsors:

M.D. Anderson Cancer CenterNational Cancer Institute (NCI)
Similarity Score4%

Anne Reb

City of Hope Medical Center

Related
4 trials

Shared therapeutic areas:

Stage IV Vaginal Cancer AJCC v8Stage IV Vulvar Cancer AJCC v8Stage IV Cervical Cancer AJCC v8

Worked with same sponsors:

National Cancer Institute (NCI)
Similarity Score4%

Filip Janku

M.D. Anderson Cancer Center

Related
4 trials

Shared therapeutic areas:

Metastatic Malignant NeoplasmRecurrent Malignant NeoplasmRefractory Malignant Neoplasm

Worked with same sponsors:

M.D. Anderson Cancer CenterNational Cancer Institute (NCI)
Similarity Score4%

Ann H Klopp

M.D. Anderson Cancer Center

Related
3 trials

Shared therapeutic areas:

Stage IVA Cervical Cancer AJCC v8Stage IVA Vaginal Cancer AJCC v8

Worked with same sponsors:

M.D. Anderson Cancer CenterNational Cancer Institute (NCI)
Similarity Score3%

Publications (0)

No publications found for this investigator.

Clinical Trials (1)

Showing 1 of 1 trials

NCT03439085Phase 2PrincipalInvestigator

DNA Plasmid-encoding Interleukin-12/HPV DNA Plasmids Therapeutic Vaccine INO-3112 and Durvalumab in Treating Patients With Recurrent or Metastatic Human Papillomavirus Associated Cancers

Human Papillomavirus-16 PositiveHuman Papillomavirus-18 PositiveMetastatic Malignant Neoplasm+18 more
Terminated

All 1 trials loaded